SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jean-Robert Grenier who wrote (455)10/1/1998 9:08:00 AM
From: Richard Haugland  Read Replies (1) of 783
 
I find only one Medline citation on AE-941, AEterna's drug candidate and its possible used for treating psoriasis. No mention of it being in phase 3 in that report, however.

J Cutan Med Surg 1998 Jan;2(3):146-52

Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis. Dupont E, Savard PE, Jourdain C, Juneau C, Thibodeau A, Ross N, Marenus K, Maes DH, Pelletier G, Sauder DN

Les Laboratoires Aeterna, Ste-Foy, PQ, Canada.

ncbi.nlm.nih.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News